Shield Therapeutics (GB:STX) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Shield Therapeutics is set to raise $10 million through a share subscription agreement with AOP Health, contingent on shareholder approval, which would grant AOP a controlling stake. Additionally, the company plans a RetailBook Offer to raise up to £1 million from existing retail shareholders. This financial maneuver is crucial for Shield’s goal of becoming cash flow positive by the end of 2025.
For further insights into GB:STX stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Deutsche Bank Weighs in on Robinhood Stock Amid Soaring Trading Volumes
- Paramount Global (NASDAQ:PARA) Deal May Face Risks from Trump Administration
- Ford’s (NYSE:F) Electric Vehicle Motor Production Begins
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
